Validación del método analítico por HPLC para la cuantificación de trazas del fármaco Meloxicam en equipos y áreas de fabricación.

Saved in:

Bibliographic Details
Title:	Validación del método analítico por HPLC para la cuantificación de trazas del fármaco Meloxicam en equipos y áreas de fabricación.
Alternate Title:	Validation of the analytical method by HPLC for the quantification of trace amounts of the drug Meloxicam in equipment and manufacturing areas.
Authors:	Rojas, Kelly Johana¹ kelly.rojas@correounivalle.edu.co, Afanasjeva, Natalia²
Source:	NOVA: Publicación Científica en Ciencias Biomédicas. ene-jun2026, Vol. 24 Issue 46, p95-116. 22p.
Subjects:	High performance liquid chromatography, Nonsteroidal anti-inflammatory agents, Quality control, Pharmaceutical chemicals manufacturing, Tropical climate
Abstract (English):	Introduction. In the pharmaceutical industry, the quantification of trace amounts of active ingredients in drugs is essential to validate post-manufacturing cleaning processes, given the risk of cross-contamination resulting from inadequate cleaning process. Objective. To validate an analytical methodology in tropical climate conditions to quantify traces of the non-steroidal anti-inflammatory drug (NSAID) or Meloxicam in manufacturing equipment using high performance liquid chromatography (HPLC). Methodology. The analysis was carried out on Zorbax Eclipse XDB-C18 column (4.6 x 150 mm, 5 µm, Agilent) at 30°C ± 2°C. The mobile phase consisted of 90% monobasic ammonium phosphate buffer (pH 7.0) with 2-propanol and methanol, and 10% methanol, at a flow rate of 1.0 mL/min. Detection was performed at 360 nm, with an injection volume of 10 µL, and the same mobile phase was used as diluent. Results. The method showed excellent linearity, with a statistical correlation coefficient R ≥ 0.999. The coefficient of variation did not exceed the RSD limit of 13% in the repeatability of the system in all the surfaces evaluated and in intermediate precision the criterion of RSD < 20.0% was fulfilled. Accuracy test yielded a recovery percentage above the acceptance criterion of 50%. There were no interferences in the specificity. Conclusions. The studies performed validate the proposed HPLC methodology for the quantification of Meloxicam traces by HPLC, showing that is precise, accurate, selective, efficient, robust and suitable to carry out in pharmaceutical analysis laboratories. Moreover, the optimization of critical parameters un tropical climate conditions, such as filter type, time and nature of the extraction solvent, as well as the stability of the method, also provided a solid basis for its implementation in the quality control area. [ABSTRACT FROM AUTHOR]
Abstract (Spanish):	Introducción. En la industria farmacéutica la cuantificación de trazas de principios activos de los medicamentos es crucial para validar los procesos de limpieza post-fabricación, debido al riesgo de contaminación cruzada cuando se ejecuta un proceso de limpieza inadecuado. Objetivo. Validar una metodología analítica en condiciones del clima tropical para cuantificar trazas de medicamento antiinflamatorio no esteroideo (AINES) o Meloxicam en equipos de fabricación utilizando cromatografía líquida de alta eficiencia (HPLC). Metodología. Se empleó una columna Zorbax Eclipse XDB-C18 (4.6 x 150 mm, 5 µm, Agilent) a 30°C ± 2°C, donde la fase móvil consistió en un 90% de un buffer fosfato de amonio monobásico (pH=7.0) con 2-propanol y metanol, y un 10% de metanol, a un flujo de 1,0 mL/min, la detección se realizó a 360 nm, con un volumen de inyección de 10 µL, y como diluente se usó la misma fase móvil. Resultados. Para la linealidad del método empleado se obtuvo un coeficiente estadístico de correlación R ≥ 0,999, el coeficiente de variación no superó el límite RSD de 13%, en la repetibilidad del sistema en todas las superficies evaluadas y en precisión intermedia se cumplió el criterio de RSD < 20,0%. En exactitud, se encontró un porcentaje de recuperación mayor al criterio de aceptación de 50%. No se presentaron las interferencias en la determinación de especificidad. Conclusiones. Los estudios realizados validan la metodología analítica propuesta para la cuantificación de trazas de Meloxicam por HPLC, asegurando que es precisa, exacta, selectiva, eficaz, robusta y adecuada para su aplicación en laboratorios farmacéuticos de análisis, y la optimización de los parámetros críticos en condiciones del clima tropical, como el tipo de filtro, tiempo y naturaleza del solvente de extracción, así como la estabilidad del método, además proporcionaron una base sólida para su implementación en el área de control de calidad. [ABSTRACT FROM AUTHOR]
	Copyright of NOVA: Publicación Científica en Ciencias Biomédicas is the property of Universidad Colegio Mayor de Cundinamarca and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	MedicLatina

Description
Abstract:	Introduction. In the pharmaceutical industry, the quantification of trace amounts of active ingredients in drugs is essential to validate post-manufacturing cleaning processes, given the risk of cross-contamination resulting from inadequate cleaning process. Objective. To validate an analytical methodology in tropical climate conditions to quantify traces of the non-steroidal anti-inflammatory drug (NSAID) or Meloxicam in manufacturing equipment using high performance liquid chromatography (HPLC). Methodology. The analysis was carried out on Zorbax Eclipse XDB-C18 column (4.6 x 150 mm, 5 µm, Agilent) at 30°C ± 2°C. The mobile phase consisted of 90% monobasic ammonium phosphate buffer (pH 7.0) with 2-propanol and methanol, and 10% methanol, at a flow rate of 1.0 mL/min. Detection was performed at 360 nm, with an injection volume of 10 µL, and the same mobile phase was used as diluent. Results. The method showed excellent linearity, with a statistical correlation coefficient R ≥ 0.999. The coefficient of variation did not exceed the RSD limit of 13% in the repeatability of the system in all the surfaces evaluated and in intermediate precision the criterion of RSD < 20.0% was fulfilled. Accuracy test yielded a recovery percentage above the acceptance criterion of 50%. There were no interferences in the specificity. Conclusions. The studies performed validate the proposed HPLC methodology for the quantification of Meloxicam traces by HPLC, showing that is precise, accurate, selective, efficient, robust and suitable to carry out in pharmaceutical analysis laboratories. Moreover, the optimization of critical parameters un tropical climate conditions, such as filter type, time and nature of the extraction solvent, as well as the stability of the method, also provided a solid basis for its implementation in the quality control area. [ABSTRACT FROM AUTHOR]
ISSN:	17942470